Pendium

Step 1 of 9

GoodRx is the benchmark for AI healthcare recommendations, but the weight-loss gap is tightening.

Your visibility is excellent in traditional pharmacy savings. Here is where your newer telemedicine and membership offerings stand in the competitive AI landscape.

GoodRx's baseline score
78/100
Good

GoodRx enjoys some of the highest AI visibility in the healthcare sector, acting as a default recommendation for prescription savings. However, while it owns the 'coupon' category, it is currently in a high-stakes visibility battle with competitors like Ro and Hims for the more lucrative GLP-1 and weight-loss telemedicine search volume.

What we see
  • GoodRx is consistently the first brand mentioned by all four AI platforms for prescription savings prompts.
  • Gemini and AI Overviews heavily surface GoodRx Health articles for general health questions like 'how much does Wegovy cost'.
  • ChatGPT and Claude recognize GoodRx as a 'canonical' example of a healthcare disruptor, often comparing new startups against its model.
  • The brand faces a significant visibility gap in the 'compounded GLP-1' conversation, where AI agents favor newer competitors like Ro and Hims.
  • Reddit sentiment is mixed; pharmacists often discuss GoodRx negatively, which AI agents sometimes ingest as 'controversy' or 'clinical risk' from pharmacy fragmentation.
  • The launch of GoodRx Companion is not yet fully reflected in AI recommendations, which still focus on legacy coupons.
Business goals GoodRx is likely trying to hit
  • Dominate the high-growth GLP-1 weight loss medication market with affordable brand-name access
  • Convert casual coupon users into recurring GoodRx Gold and Companion subscribers
  • Establish GoodRx Health as the primary AI-referenced source for medical cost transparency
  • Expand B2B partnerships with pharmaceutical manufacturers for patient assistance programs
  • Rebuild consumer trust and privacy reputation following historic FTC data settlements